# Irbesartan and Atenolol in Hypertensive Heart Disease

> **NCT00389168** · PHASE2,PHASE3 · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 115 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Irbesartan
- **DRUG:** Atenolol

## Key facts

- **NCT ID:** NCT00389168
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-04
- **Primary completion:** 1997-04
- **Final completion:** 1997-04
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2015-05-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389168, "Irbesartan and Atenolol in Hypertensive Heart Disease". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00389168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*